Medlab Clinical Ltd. (MDLB)

Medlab Clinical Statistics

Total Valuation

Medlab Clinical has a market cap or net worth of $18.16 million. The enterprise value is $14.09 million.

Market Cap	18.16M
Enterprise Value	14.09M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Medlab Clinical has 4.08 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	4.08M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.82
Forward PS	n/a
PB Ratio	2.34
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	9.17
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	2.11
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-125.40

Financial Efficiency

Return on equity (ROE) is -93.29% and return on invested capital (ROIC) is -146.35%.

Return on Equity (ROE)	-93.29%
Return on Assets (ROA)	-63.60%
Return on Invested Capital (ROIC)	-146.35%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	$36,580
Profits Per Employee	-$170,534
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medlab Clinical had revenue of $1.54 million and -$7.16 million in losses. Loss per share was -$1.75.

Revenue	1.54M
Gross Profit	1.20M
Operating Income	-12.98M
Pretax Income	-7.16M
Net Income	-7.16M
EBITDA	-6.32M
EBIT	-7.17M
Loss Per Share	-$1.75

Balance Sheet

The company has $5.19 million in cash and $1.12 million in debt, giving a net cash position of $4.07 million or $1.00 per share.

Cash & Cash Equivalents	5.19M
Total Debt	1.12M
Net Cash	4.07M
Net Cash Per Share	$1.00
Equity (Book Value)	7.75M
Book Value Per Share	1.90
Working Capital	6.75M

Cash Flow

In the last 12 months, operating cash flow was -$9.41 million and capital expenditures -$31,135, giving a free cash flow of -$9.44 million.

Operating Cash Flow	-9.41M
Capital Expenditures	-31,135
Free Cash Flow	-9.44M
FCF Per Share	-$2.31

Margins

Gross margin is 78.11%, with operating and profit margins of -845.13% and -466.19%.

Gross Margin	78.11%
Operating Margin	-845.13%
Pretax Margin	-466.19%
Profit Margin	-466.19%
EBITDA Margin	-411.42%
EBIT Margin	-466.79%
FCF Margin	-614.57%

Dividends & Yields

Medlab Clinical does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-39.44%
FCF Yield	-51.99%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medlab Clinical has an Altman Z-Score of -5.55. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.55
Piotroski F-Score	n/a